T0	Outcomes 903 960	lower incidence of both local and systemic adverse events
T1	Outcomes 990 1004	Immunogenicity
T2	Outcomes 1094 1192	pertussis toxin, filamentous hemagglutinin, pertactin and polioviruses 1, 2 and 3 in the Pa group.
T3	Outcomes 1377 1406	geometric mean concentrations